A polymorphism of DRD2 gene and brain atrophy in methamphetamine psychosis

Annals of the New York Academy of Sciences

Volumn 1025, Issue , 2004, Pages 307-315

  Harano, M ^a,m   Uchimura, N ^a   Abe, H ^a   Ishibashi, M ^b   Iida, N ^c   Yanagimoto, K ^d   Tanaka, T ^d   Maeda, H ^a   Sora, I ^e   Iyo, M ^f   Komiyama, T ^g   Yamada, M ^h   Sekine, Y ⁱ   Inada, T ^j   Ozaki, N ^k   Ujike, H ^l  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Jyuzen Hospital   (Japan)

^c Kaisei Hospital   (Japan)

^d Taihozan Hospital   (Japan)

^e TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f CHIBA UNIVERSITY   (Japan)

^g NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^h SHOWA UNIVERSITY   (Japan)

ⁱ HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l OKAYAMA UNIVERSITY   (Japan)

^m NONE   (Japan)

more..

Author keywords

Atrophy; Dopamine; Gene polymorphism; Methamphetamine psychosis; MRI; TaqI A

Indexed keywords

DOPAMINE 2 RECEPTOR; METHAMPHETAMINE; TAQ POLYMERASE;

ADULT; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DNA POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PSYCHOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TEMPORAL LOBE;

EID: 10444285075     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1316.038     Document Type: Conference Paper

References (12)

1. IYO, M. et al. 1993. Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography. Psychiatry Res. 50:217-231.
2. BUXTON, N. et al. 2000. Amphetamine abuse and intracranial haemorrhage. J.R. Soc. Med. 93: 472-477.
3. OGASAWARA, K. et al. 1986. Intracerebral hemorrhage and characteristic angiographic changes associated with metharnphetamine - a case report. No To Shinkei 38: 967-971.
4. PEREZ, J.A., JR. et al. 1999. Methamphetamine-related stroke: four cases. J. Emerg. Med. 17:469-471.
5. SHIBATA, S. et al. 1988. An autopsy case of subarachnoid and intracerebral hemorrhage and necrotizing angitis associated with methamphetamine abuse. No To Shinkei 40: 1089-1094.
6. YEN, D.J. et al. 1994. Stroke associated with methamphetamine inhalation. Eur. Neurol. 34: 16-22.
7. SHIBATA, S. et al. 1991. Subarachnoid and intracerebral hemorrhage associated with necrotizing angiitis due to methamphetamine abuse - an autopsy case. Neurol. Med.-Chir. (Tokyo). 31: 49-52.
8. STUMM, G. et al. 1999. Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J. 13: 1065-1072.
9. UJIKE, H. et al. 2001. D2 Dopamine receptor alleles influences prognosis of methamphetamine psychosis. Am. J. Med. Genet. 105: 617.
10. UJIKE, H. et al. 2001. Association study between methamphetamine psychosis and the dopamine transporter gene polymorphisms. Int. Clin. Psychopharmacol. 17: S45-S46.
11. UJIKE, H. et al. 2003. Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis. Pharmacogenomics J. 3: 242-247.
12. ASHBURNER, J. et al. 2000. Voxel-based morphometry - the methods. Neuroimage 11: 805-821.